PINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.834
EU - Europa 2.610
AS - Asia 1.006
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 7
OC - Oceania 6
Totale 8.489
Nazione #
US - Stati Uniti d'America 4.819
UA - Ucraina 779
CN - Cina 732
IT - Italia 507
DE - Germania 321
PL - Polonia 222
IE - Irlanda 209
GB - Regno Unito 179
FI - Finlandia 177
IN - India 162
BE - Belgio 88
VN - Vietnam 53
FR - Francia 49
SE - Svezia 44
SG - Singapore 27
CA - Canada 15
MU - Mauritius 13
TR - Turchia 13
EU - Europa 12
AU - Australia 6
MK - Macedonia 6
RU - Federazione Russa 6
JP - Giappone 5
NL - Olanda 5
RO - Romania 5
NO - Norvegia 4
CY - Cipro 3
GR - Grecia 3
ID - Indonesia 3
AR - Argentina 2
BR - Brasile 2
CL - Cile 2
IR - Iran 2
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
IM - Isola di Man 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 8.489
Città #
Fairfield 600
Jacksonville 584
Woodbridge 548
Chandler 449
Houston 382
Princeton 364
Ashburn 277
Wilmington 262
Ann Arbor 234
Cambridge 231
Warsaw 221
Seattle 207
Dublin 186
Nanjing 170
Brescia 163
Nanchang 90
Brussels 88
Helsinki 75
Des Moines 73
San Diego 57
Verona 57
Dong Ket 53
Shenyang 53
Changsha 49
Hebei 49
Beijing 48
Jinan 46
Lancaster 46
Jiaxing 37
Tianjin 36
Washington 31
London 29
Milan 29
Hangzhou 22
Kunming 22
San Francisco 22
Trento 17
Menlo Park 15
Zhengzhou 15
Azzano 14
Haikou 14
Lanzhou 12
Guangzhou 11
New Bedfont 11
Taizhou 11
Dearborn 10
Ningbo 9
Norwalk 9
Cazzago San Martino 8
Rome 7
Toronto 7
Changchun 6
Fuzhou 6
Gunzenhausen 6
Islington 6
Skopje 6
Taiyuan 6
Kocaeli 5
Tokyo 5
Bergamo 4
Chiswick 4
Leawood 4
New York 4
Piangipane 4
Albino 3
Bari 3
Canberra 3
Markham 3
Milano 3
Montichiari 3
Orange 3
Oslo 3
Patras 3
Redmond 3
Rende 3
Abbiategrasso 2
Braunschweig 2
Chicago 2
Corte 2
Council Bluffs 2
Cremona 2
Eskilstuna 2
Ferrara 2
Frankfurt am Main 2
Hanover 2
Kandukur 2
Lappeenranta 2
Magenta 2
Mantova 2
Modena 2
Monmouth Junction 2
Monza 2
Mountain View 2
Mumbai 2
New Delhi 2
Ottawa 2
Riccione 2
Rockville 2
San Mateo 2
Santa Caterina Dello Ionio 2
Totale 6.209
Nome #
Central airways remodeling in COPD patients 136
Il deficit di Alfa1-Anti-tripsina. 134
Methods for Measuring Lung Volumes: Is There a Better One? 109
Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement 108
Vitamin D and health status in elderly. 107
Tidal airway closure during bronchoconstriction in asthma: usefulness of lung volume measurements. 104
Acute dynamic hyperinflation and systemic inflammation in stable COPD patients. 101
Alpha1-antitrypsin deficiency-associated cervical artery dissection. Report of three cases. 98
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 92
Airway remodeling in allergen-challenged Brown Norway rats: Distribution of proteoglycans 92
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients 92
Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 92
Long-term physical training leads to airway remodelling in animal model. 90
The role of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 88
Epatocirrosi e versamento pleurico recidivante (idotorace epatico). 86
Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. 84
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 84
Predictors of nocturnal oxyhemoglobin desaturation in COPD. 83
Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction 83
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 83
Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. 82
Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. 81
Diagnostic flow chart for targeted detection of alpha-1-antitrypsin deficiency 79
Diagnostic flow chart for targered detection of Alpha-1-antitrypsin deficiency. 79
Dose-Response curve to salbutamol during acute and chronic treatment with formoterol in COPD. 78
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 75
Effect of PEEP on induced constriction is enhanced in decorin-deficient mice 74
Tidal airway closure in asthma and COPD 74
Do GOLD stages of COPD severity really correspond to differences in health status? 71
Diagnostic flow chart for targeted detection of Alpha1-antitrypsin deficiency. 70
Dynamic pulmonary hyperinflation and low grade systemic inflammaton in stable COPD patients. 68
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments 68
Daytime approach to Obstructive Sleep Apnea phenotyping 67
L'anziano di fronte ai problemi chirurgici: " I fattori di rischio" respiratori. 66
Alpha1-Antitrypsin Deficiency in Spontaneous Cerebral Arterial Dissection. 66
Alpha1-antitrypsin deficiency. The Brescia (Italy) clinical study [Il deficit di alfa1-antitripsina: Lo studio clinico di Brescia] 65
Angiotensin II - receprot (AT1) blockade reduces ventricul arrhythimias in uncomplicated essential hypertensive patients. 63
Deficit di Alfa1-antitripsina. 61
Effect of training on airways inflammatory response and remodeling in a rat model. 61
Assessment of expiratory flow limitation in subjects with severe alpha-1-antitrypsin deficiency. 60
Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study 58
Alpha1-antitrypsin deficiency and arterial dissection: report of four cases 57
Alpha1-antitrypsin Deficiecy and nephropathy 57
Il deficit di alfa-1-antitripsina: lo studio clinico di Brescia. 56
Early effects of CPAP on elastic aortic properties. 55
Inhaled corticosteroids in COPD: Trying to make a long story short 55
Predictors of exercise-induced airways obstruction in patients with mild asthma 55
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 55
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 55
Airway obstruction or closure during bronchoconstricction in asthma: can we preconize it? 54
ELASTIC PROPERTIES OF THE ASCENDING AORTA IN PATIENTS WITH ALPHA1-ANTITRYPSIN DEFICIENCY (Z-HOMOZYGOTES) 54
Valutazione ecocardiografica in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 54
Alpha1-antitrypsin deficiency and abdominal aortic aneurysms: does this association really exist? 54
Alpha-1-antitrypsin deficiency - The Brescia Clinical Study. 53
Role of respiratory mechanics in the pathogenesis of airway hyperresponsiveness in obese subject. 52
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 52
Assessment of expiratory flow limitation in subjects with severe alpha-1-Antitrypsin deficiency. alpha-1-antitrypsin deficiency - the biochemical basis of pulmonary emphysema. 51
Effect of precedine inspiratory speed and end-inspiratory on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients. 51
Characteristics and treatment regimens across ERS SHARP severe asthma registries 51
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 51
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 51
Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I. 50
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 50
Intra-epithelial polymerization, accumulation and secretion of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 49
Vasodilators and diuretics control orthopnea also by reversing expiratory flow limitation in subjects with chronic heart failure. 49
COPD: It is time to change! 49
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 49
Consequences of SARS-COV-2 Pneumonia on Lung function 49
Long-term physical training leads to airway remodelling in animal model. 48
Effects of Chronic and Acute Pulmonary Hyperinflation on Phrenic Nerve Conduction in Patients with COPD 48
Role of sighs and breathing pattern in the pathogenesis of airway hyperresponsiveness in healty obese subjects. 47
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 47
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 47
Alpha1-antitrypsin deficiency in spontaneous cerebral arterial dissection 46
Respiratory mechanics in pathogenesis of AHR in obese subjects. 46
The role of exercise testing to assess the disability by silicosis in Italy. 46
In patients with bronchiectasis. is a casistis overview. 46
Proprietà elastiche dell’aorta ascendente in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 46
Dyspnea during night-time and at early morning in patients with stable copd is associated with supine tidal expiratory flow limitation 46
Alpha1-antitrypsin deficiency and asthma 46
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 46
Intermediate alpa1-antitrysin deficiency: A cross sectional clinical study. 45
Severe alpha1-antitrypsin deficiency. a cross-sectional clinical study. 45
Severe alpha-1-antitrypsin deficiency : a cross-sectional clinical study. 45
Has cardio-pulmonary exercise testing a role in detecting early emphysema in alpha-1-antitrysin deficiency? 45
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 45
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 45
Intermediate alpha-1-antitrypsin deficiency: a cross-sectional clinical study. 44
Prova da sforzo cardio-respiratorio e spirometria nello screening delle patologie respiratorie nell'adulto. 44
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 44
Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry 44
Short-Term Exposure to Particulate Matter and Asthma: A Link Between Environment and Respiratory Emergencies 44
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 44
Association of autonomic neuropathy and obesità highly increases the occurence of obstructive sleep apnea syndrome (OSAS) in diabetic subjects. 43
Extracellular Matrix (ECM) Remodeling in the airways of OA challenged brown normay (BN) rats. 43
Long-term physical trainign leads to airway remodelling in animal model. 43
Differences in proteoglycan deposition in the airway of moderate and severe asthmatics. 42
Different mean 24-H ambulatory BP and hig BP distribution in hypertensive patients an age-based observational study. 42
Prevalence of bronchial hyperresponsiveness in subject with alpha-1-antitrypsin definciecy. 42
Role of respiratory mechanics in the pathogenesis of AHR in obese subjects. 42
Totale 6.266
Categoria #
all - tutte 39.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019563 0 0 9 5 100 14 65 115 4 54 106 91
2019/20201.677 352 31 33 186 55 173 182 176 61 264 36 128
2020/20212.202 71 166 53 197 197 268 100 243 295 238 238 136
2021/20221.469 68 168 46 165 29 101 55 132 95 175 123 312
2022/20231.367 208 109 60 88 85 320 6 179 151 9 47 105
2023/2024273 72 26 175 0 0 0 0 0 0 0 0 0
Totale 8.976